<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIM: Altered expression of microRNAs (miRNAs) hallmarks many <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types </plain></SENT>
<SENT sid="1" pm="."><plain>The study of the associations of miRNA expression profile and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> phenotype could help identify the links between deregulation of miRNA expression and oncogenic pathways </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Expression profiling of 866 human miRNAs in 19 colorectal and 17 <z:hpo ids='HP_0002894'>pancreatic cancers</z:hpo> and in matched adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues was investigated </plain></SENT>
<SENT sid="3" pm="."><plain>Classical paired t-test and random forest analyses were applied to identify miRNAs associated with tissue-specific <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Network analysis based on a computational approach to mine associations between <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types and miRNAs was performed </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The merge between the two statistical methods used to intersect the miRNAs differentially expressed in colon and <z:hpo ids='HP_0002894'>pancreatic cancers</z:hpo> allowed the identification of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific miRNA alterations </plain></SENT>
<SENT sid="6" pm="."><plain>By miRNA-network analysis, tissue-specific patterns of miRNA deregulation were traced: the driving miRNAs were miR-195, miR-1280, miR-140-3p and miR-1246 in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e>, and miR-103, miR-23a and miR-15b in <z:hpo ids='HP_0002894'>pancreatic cancers</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: MiRNA expression profiles may identify <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific signatures and potentially useful biomarkers for the diagnosis of tissue specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>miRNA-network analysis help identify altered miRNA regulatory networks that could play a role in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> pathogenesis </plain></SENT>
</text></document>